Skip to content

Study · Case report or series · n = 1 · 2026

1 result

Pulmonary aspiration during upper endoscopy in a patient prescribed semaglutide.

Dong T, Wang L, Wang H, Xiao J

Revista espanola de enfermedades digestivas1 Sept 2026Cited by 2 (Europe PMC)

PMID39421913 (opens in a new tab)DOI10.17235/reed.2024.10844/2024 (opens in a new tab)PepBankPUB-39421913
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesSafety outcome

    A patient who was prescribed semaglutide had pulmonary aspiration during upper endoscopy (EGD).

    In plain wordsOne patient who was prescribed semaglutide had pulmonary aspiration, a safety event, during an upper endoscopy.

    Peptide
    Semaglutide
    Outcome
    Not applicablePulmonary aspiration during upper endoscopy
    Study

    n = 1

    Outcome group
    Adverse events · Respiratory
    Studied dose
    Dose not stated

    Source sentences

    Summary
    We report a case of pulmonary aspiration during EGD in a patient prescribed semaglutide.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.